Impax Laboratories Inc., which has recently won tentative approval from the FDA for a generic version of Claritin tablets, has signed a “semi-exclusive” development, license and supply agreement with Wyeth for this drug. Claritin is marketed by Schering-Plough Corp. for the relief of symptoms of seasonal allergic rhinitis, or hay fever. Worldwide sales of the Read more about Impax Announces Otc Alliance With Wyeth[…]